Envestnet Asset Management Inc Procept Bio Robotics Corp Transaction History
Envestnet Asset Management Inc
- $302 Billion
- Q4 2024
A detailed history of Envestnet Asset Management Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 42,202 shares of PRCT stock, worth $2.51 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,202
Previous 18,341
130.1%
Holding current value
$2.51 Million
Previous $1.47 Million
131.31%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PRCT
# of Institutions
295Shares Held
41.6MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$306 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$208 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$104 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$88.8 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$71.9 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.66B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...